This webinar will be held in Japanese only. Medical writing is a critical part of drug development. It relies on manual processes which have not changed significantly over the past two decades. Drug development pipelines increasingly comprise precision medicine therapies that depend on advanced biomedical knowledge. Today’s medical writers must translate complex study designs and data into documents that contextualize research results for different audiences.
Our new writing software, CoAuthor, is an advanced writing platform designed for medical writers. It combines generative AI, document templates, Microsoft Word integration, and structured content authoring tools. In this short webinar, our Japanese local expert will highlight how the tool can be implemented and adopted in Japan for Japanese pharmaceutical companies and CROs.
For whom the webinar will be beneficial the most:
- Regulatory Affairs in Japanese pharmaceutical companies or CROs
- Medical/Regulatory Writing Team in Japanese pharmaceutical companies or CROs
Speaker: Hiromoto Yamamoto, Enterprise Account Manager, Certara G.K.